10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q3 2025

Filing Information

Form Type	10-Q
Accession Number	`0001439222-25-000116`
Period End Date	20250930
Filing Date	20251030
Fiscal Year	2025
Fiscal Period	Q3
XBRL Instance	agio-20250930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 156 Income Statement 144 Cash Flow Statement 164 Stockholders Equity 102 Comprehensive Income 32

Balance Sheet 156 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.71M	USD	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$817.46M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$817.46M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$860.15M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$860.15M	USD	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$4.11M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$4.11M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$5.03M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$5.03M	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Inventory	`InventoryNet`	$27.62M	USD	Point-in-time
Inventory	`InventoryNet`	$27.62M	USD	Point-in-time
Inventory	`InventoryNet`	$32.03M	USD	Point-in-time
Inventory	`InventoryNet`	$32.03M	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	73.37M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	73.37M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	74.50M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	74.50M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$40.16M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$40.16M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$43.19M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$43.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$965.60M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$965.60M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.03B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.03B	USD	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$638.32M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$638.32M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$304.34M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$304.34M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$42.88M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$42.88M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$33.65M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$33.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.68M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.72M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.72M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.93M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.93M	USD	Point-in-time
Total assets	`Assets`	$1.66B	USD	Point-in-time
Total assets	`Assets`	$1.66B	USD	Point-in-time
Total assets	`Assets`	$1.39B	USD	Point-in-time
Total assets	`Assets`	$1.39B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$19.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$19.55M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$46.86M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$46.86M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.22M	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$871.00K	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$871.00K	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	-	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	-	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$16.78M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$16.78M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$17.99M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$17.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$81.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$81.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$74.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$74.76M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$40.21M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$40.21M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$26.53M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$26.53M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$880.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$880.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$90.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$90.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$122.24M	USD	Point-in-time
Total liabilities	`Liabilities`	$122.24M	USD	Point-in-time
Total liabilities	`Liabilities`	$101.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$101.38M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2025 and December 31, 2024	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2025 and December 31, 2024	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2025 and December 31, 2024	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2025 and December 31, 2024	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 74,496,287 shares issued and 58,279,876 shares outstanding at September 30, 2025, and 73,372,696 shares issued and 57,156,285 shares outstanding at December 31, 2024	`CommonStockValueOutstanding`	$73.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 74,496,287 shares issued and 58,279,876 shares outstanding at September 30, 2025, and 73,372,696 shares issued and 57,156,285 shares outstanding at December 31, 2024	`CommonStockValueOutstanding`	$73.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 74,496,287 shares issued and 58,279,876 shares outstanding at September 30, 2025, and 73,372,696 shares issued and 57,156,285 shares outstanding at December 31, 2024	`CommonStockValueOutstanding`	$74.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 74,496,287 shares issued and 58,279,876 shares outstanding at September 30, 2025, and 73,372,696 shares issued and 57,156,285 shares outstanding at December 31, 2024	`CommonStockValueOutstanding`	$74.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.49B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.49B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.54B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.54B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.52M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.52M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.05M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.05M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2025 and December 31, 2024)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2025 and December 31, 2024)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2025 and December 31, 2024)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2025 and December 31, 2024)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-148.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-148.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-453.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-453.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$811.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$811.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$743.92M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$743.92M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$660.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$660.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.63B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.63B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.54B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.54B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.47B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.47B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.37B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.37B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.28B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.66B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.66B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.39B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.39B	USD	Point-in-time

Income Statement 144 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.96M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.96M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.77M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.77M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$12.88M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$12.88M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.06M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.06M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$783.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$783.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.90M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.90M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.68M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.68M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$4.47M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$4.47M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$72.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$72.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$218.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$218.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$86.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$86.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$251.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$251.48M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.54M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.54M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$41.27M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$41.27M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$128.67M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$128.67M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$111.78M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$111.78M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$326.47M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$326.47M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$129.75M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$129.75M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$384.62M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$384.62M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-102.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-102.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-300.70M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-300.70M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-116.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-116.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-350.55M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-350.55M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.06M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.06M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$30.07M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$30.07M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.37M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.37M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$43.97M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$43.97M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.65M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.65M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$4.86M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$4.86M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$67.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$67.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.84M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.84M	USD	3 Qtrs
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00B	USD	1 Quarter
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00B	USD	1 Quarter
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$823.37M	USD	3 Qtrs
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$823.37M	USD	3 Qtrs
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.43M	USD	1 Quarter
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.43M	USD	1 Quarter
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-304.74M	USD	3 Qtrs
Net (loss) income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-304.74M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$16.65	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$16.65	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$13.58	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$13.58	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.78	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.78	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-5.27	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-5.27	USD	3 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$16.22	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$16.22	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$13.38	USD	3 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$13.38	USD	3 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.78	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.78	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-5.27	USD	3 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-5.27	USD	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.94M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.94M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.71M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.71M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	58.14M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	58.14M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	57.85M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	57.85M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.43M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.43M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.58M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.58M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.14M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.14M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.85M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.85M	shares	3 Qtrs

Cash Flow Statement 164 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.29M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.29M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$3.91M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$3.91M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.94M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.94M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$38.43M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$38.43M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$8.87M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$8.87M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.44M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.44M	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$39.00K	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$39.00K	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-304.00K	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-304.00K	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.57M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.57M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$9.23M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$9.23M	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	$10.00M	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	$10.00M	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$168.00K	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$168.00K	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$308.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$308.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$920.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$920.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$7.35M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$7.35M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$4.42M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$4.42M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.86M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.86M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.23M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.23M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.89M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.89M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.86M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.86M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.64M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.64M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$52.68M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$52.68M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-871.00K	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-871.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.16M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.16M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-12.47M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-12.47M	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-790.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-790.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-256.67M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-256.67M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-276.76M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-276.76M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.34B	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.34B	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$480.68M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$480.68M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$668.25M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$668.25M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.99M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.99M	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	$10.00M	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	$10.00M	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	-	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	-	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromDivestitureOfBusinesses`	$200.00M	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromDivestitureOfBusinesses`	$200.00M	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$718.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$718.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.20M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.20M	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$40.00K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$40.00K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	-	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$412.60M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$412.60M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$287.11M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$287.11M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.60M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.60M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$6.12M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$6.12M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.60M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.60M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.12M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.12M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$165.53M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$165.53M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$16.46M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$16.46M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.25M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.25M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$92.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$92.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.25M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.25M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$92.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$92.71M	USD	Point-in-time
Additions to property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$61.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$61.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$336.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$336.00K	USD	3 Qtrs
Net cash taxes paid (returned)	`IncomeTaxesPaidNet`	$-637.00K	USD	3 Qtrs
Net cash taxes paid (returned)	`IncomeTaxesPaidNet`	$-637.00K	USD	3 Qtrs
Net cash taxes paid (returned)	`IncomeTaxesPaidNet`	$1.57M	USD	3 Qtrs
Net cash taxes paid (returned)	`IncomeTaxesPaidNet`	$1.57M	USD	3 Qtrs

Stockholders Equity 102 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.54B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.54B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.47B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.47B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.28B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.28B	USD	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$646.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$646.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-42.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-42.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-1.88M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-1.88M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-290.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-290.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-1.40M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-1.40M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	93,389.00	shares	3 Qtrs
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	93,389.00	shares	3 Qtrs
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.86M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.86M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.64M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.64M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.62M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.62M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$65.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$65.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.43M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.43M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.23M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.23M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.36M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.36M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.69M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.69M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.38M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.38M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	57.16M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	58.28M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.54B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.54B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.47B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.47B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.28B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.28B	USD	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-89.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-112.02M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-103.43M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-304.74M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.86M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.86M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.40M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.40M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.57M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.57M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$952.38M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$952.38M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$774.11M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$774.11M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-102.04M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-102.04M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-301.17M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-301.17M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.